Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people notice the first Mounjaro side effects within 24 to 72 hours of their initial injection, though for some the gut takes up to a week to respond. Nausea is the most commonly reported early symptom; it tends to peak in the first two or three days after a dose and then ease as the week goes on. These are prescription-only medicines, and a GPhC-registered prescriber reviews your health in full before any treatment starts — so if you have specific concerns about how your body might react, that conversation happens before your first pen arrives.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide slows how quickly your stomach empties and dials down appetite signals via two gut-hormone pathways: GIP and GLP-1. That slowing is also the reason nausea shows up so promptly. In the first day or two after injection, food lingers in the stomach for longer than usual, and the brain receives stronger fullness signals than it is accustomed to. The result for many people is mild queasiness, a reduced appetite that feels almost abrupt, and occasionally loose stools or some bloating.
Not everyone experiences this. Some people inject on a Friday evening and feel nothing unusual by Monday morning. Others feel noticeably nauseous for two or three days. Both responses fall within the range that the NHS medicines guidance on tirzepatide describes as common, meaning they affect between one in ten and one in one hundred people in clinical data. If you want a clearer sense of how long it typically takes for Mounjaro side effects to start, the timing varies more than most people expect and is worth understanding before your first injection. A practical habit worth building from day one: keep a brief note on your phone after each injection, just the date, any symptoms and their rough severity on a scale of one to ten. It takes under a minute and gives your prescriber something concrete to work with at your next review rather than a vague memory from weeks earlier.
The 2.5 mg starting dose is not the dose at which most people see meaningful weight loss; its job is to let your digestive system adjust gradually. Side effects at this level are usually at their mildest. For many people, by week three or four they have largely settled.
The challenge comes at each step up. When the prescriber increases to 5 mg (or later to 7.5 mg and beyond) a proportion of people experience a second, shorter wave of nausea or loose stools in the 48 to 72 hours that follow. This pattern tends to diminish with each subsequent increase as the gut adapts. It is one of the clearest reasons the graduated titration schedule exists; trying to shortcut it is not clinically sensible, and the broader picture of Mounjaro side effects makes more sense once you understand why timing is built into the design.
Injection-site reactions (redness, a small raised area, mild bruising) are also reported most often in the first few weeks, before technique becomes second nature. Rotating between the abdomen, thigh and upper arm at each injection helps. Our clinical FAQs cover technique questions that come up regularly.
By the end of the first month, the majority of people on Mounjaro report that the early nausea has become background noise or has gone entirely. Appetite suppression remains (that is the intended effect) but the discomfort tends to separate from it over time. Reading about Mounjaro side effects alongside weight loss before and after experiences can help set realistic expectations for how this transition tends to feel in practice. Energy levels often stabilise; some people report their best sleep improving as weight changes.
What should not be normalised at any stage is severe, persistent abdominal pain, particularly pain that radiates towards the back or arrives with vomiting that will not settle. The MHRA's January 2026 Drug Safety Update on GLP-1 medicines specifically highlighted acute pancreatitis as a known, if infrequent, serious risk. Stop the injection and seek urgent medical help if that pattern appears. Other symptoms that warrant prompt contact with a prescriber rather than watchful waiting include signs of a gallbladder problem (sudden right-sided abdominal pain after eating), any allergic response such as swelling of the face or lips, or symptoms of severe dehydration from prolonged vomiting or diarrhoea.
You can find a fuller account of when Mounjaro side effects tend to start and peak if you want to map your own experience against the clinical pattern. For anything that worries you during treatment, our support team is available seven days a week.
The short answer: if a symptom is severe, does not ease within a day or two, or feels qualitatively different from ordinary digestive discomfort, act rather than wait. Tirzepatide is a Black Triangle (▼) medicine, meaning the MHRA collects additional safety data on it beyond the standard post-approval period. Your Yellow Card report at yellowcard.mhra.gov.uk genuinely contributes to that picture, it is not a formality.
The specific signs that need same-day or emergency attention are: severe and persistent stomach pain spreading to the back (possible pancreatitis); sudden difficulty breathing or swallowing, rash or swelling (possible allergic reaction); signs of serious dehydration such as dark urine, dizziness and inability to keep fluids down; and any thoughts of self-harm or a sudden, marked change in mood. These are rare. Knowing them in advance is not cause for anxiety, it is basic safety literacy for anyone on a GLP-1 medicine.
If you are considering starting treatment and want to discuss how your personal health history might shape your experience, our prescribers talk through suitability and likely side effects as part of the free consultation, before any prescription is written. There is also more context on what the timing of side effects looks like in practice for people switching from another treatment or starting fresh. Accounts such as Jenni Murray's experience of Mounjaro side effects offer a useful real-world perspective for anyone weighing up what the treatment involves.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.